Epithelioid and epithelial neoplasms of bone

Archives of Pathology and Laboratory Medicine

Volumn 131, Issue 2, 2007, Pages 205-216

  Deyrup, Andrea T ^a,c   Montag, Anthony G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMELOBLASTOMA; ANGIOSARCOMA; ANTIGEN EXPRESSION; BONE METASTASIS; BONE TUMOR; CHONDROBLASTOMA; CHORDOMA; DIFFERENTIAL DIAGNOSIS; EPITHELIOID CELL; EPITHELIOID SARCOMA; HEMANGIOENDOTHELIOMA; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; OSTEOBLASTOMA; OSTEOSARCOMA; REVIEW; TUMOR CELL; TUMOR DIAGNOSIS;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; TUMOR MARKERS, BIOLOGICAL;

EID: 33847004336     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Antonescu CR, Erlandson RA, Huvos AG. Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature review. Am J Surg Pathol. 1997;21:1281-1294.
2. Chow LT, Lui YH, Kumta SM, Allen PW. Primary sclerosing epithelioid fibrosarcoma of the sacrum: a case report and review of the literature. J Clin Pathol. 2004;57:90-94.
3. Abdulkader I, Cameselle-Teijeiro J, Fraga M, Caparrini A, Forteza J. Sclerosing epithelioid fibrosarcoma primary of the bone. Int J Surg Pathol. 2002;10:227-230.
4. Wesche WA, Khare V, Rao BN, Bowman LC, Parham DM. Malignant peripheral nerve sheath tumor of bone in children and adolescents. Pediatr Dev Pathol. 1999;2:159-167.
5. Zhang HY, Yang GH, Chen HJ, et al. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma. Chin Med J (Engl). 2005;118:1451-1461.
6. Insabato L, De Rosa G, Terracciano LM, Fazioli F, Di Santo F, Rosai J. Primary monotypic epithelioid angiomyolipoma of bone. Histopathology. 2002;40:286-290.
7. Rosai J. Histiocytoid hemangioma: a proposal of a new entity which embraces previously described diseases of heart, blood vessels, skin, bone and other sites. J Fla Med Assoc. 1980;67:190-191.
8. Fletcher CDM, Unni KK, Mertens FM, eds. Pathology and Genetics of Soft Tissue and Bone. Lyon, France: IARC Press; 2002. World Health Organization Classification of Tumours.
9. Weiss SW, Ishak KG, Dail DH, Sweet DE, Enzinger FM. Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol. 1986;3:259-287.
10. Meis-Kindblom JM, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol. 1998;22:683-697.
11. O'Connell JX, Nielsen GP, Rosenberg AE. Epithelioid vascular tumors of bone: a review and proposal of a classification scheme. Adv Anat Pathol. 2001;8(2):74-82.
12. Sung MS, Kim YS, Resnick D. Epithelioid hemangioma of bone. Skeletal Radiol. 2000;29:530-534.
13. O'Connell JX, Kattapuram SV, Mankin HJ, Bhan AK, Rosenberg AE. Epithelioid hemangioma of bone: a tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol. 1993;17:610-617.
14. Tsuneyoshi M, Dorfman HD, Bauer TW. Epithelioid hemangioendothelioma of bone: a clinicopathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol. 1986;10:754-764.
15. Kleer CG, Unni KK, McLeod RA. Epithelioid hemangioendothelioma of bone. Am J Surg Pathol. 1996;20:1301-1311.
16. Balicki D, Buhrmann R, Maclean J, et al. Multicentric epithelioid angiosarcoma of the bone. Pitfalls in clinical and morphological diagnosis. Blood Cells Mol Dis. 1996;22:205-213.
17. Hasegawa T, Fujii Y, Seki K, et al. Epithelioid angiosarcoma of bone. Hum Pathol 1997;28:985-989.
18. Santeusanio G, Bombonati A, Tarantino U, et al. Multifocal epithelioid angiosarcoma of bone: a potential pitfall in the differential diagnosis with metastatic carcinoma. Appl Immunohistochem Mol Morphol. 2003;11:359-363.
19. Deshpande V, Rosenberg AE, O'Connell JX, Nielsen GP. Epithelioid angiosarcoma of the bone: a series of 10 cases. Am J Surg Pathol. 2003;27:709-716.
20. Evans HL, Raymond AK, Ayala AG. Vascular tumors of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol. 2003;34:680-689.
21. Wenger DE, Wold LE. Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol. 2000;29:619-631.
22. Wold LE, Swee RG, Sim FH. Vascular lesions of bone. Pathol Annu. 1985;20(pt2):101-137.
23. Keel SB, Rosenberg AE. Hemorrhagic epithelioid and spindle cell hemangioma: a newly recognized, unique vascular tumor of bone. Cancer. 1999;85:1966-1672.
24. Campanacci M, Boriani S, Giunti A. Hemangioendothelioma of bone: a study of 29 cases. Cancer. 1980;46:804-814.
25. Wold LE, Unni KK, Beabout JW, Ivins JC, Bruckman JE, Dahlin DC. Hemangioendothelial sarcoma of bone. Am J Surg Pathol. 1982;6:59-70.
26. Dorfman HD, Czerniak B. Bone Tumors. St Louis, Mo: Mosby; 1998.
27. Unni KK. Bone Tumors: General Aspects and Data on 11,087 Cases. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1996.
28. Folpe AL, Chand EM, Goldblum JR, Weiss SW. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol. 2001;25:1061-1066.
29. Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17:547-552.
30. Krause M, Tunn PU, Schneider U. Hemangiosarcoma of the bone: problems arising from the heterogeneity of malignant vascular tumors of the bone. Onkologie. 2001;24:486-489.
31. Fischer B. Uber ein primares Adamantinom der Tibia. Frankfurt Ztschr Pathol. 1913;12:422.
32. Huvos AG, Marcove RC. Adamantinoma of long bones: a clinicopathological study of fourteen cases with vascular origin suggested. J Bone Joint Surg Am. 1975;57:148-154.
33. Rosai J. Adamantinoma of the tibia: electron microscopic evidence of its epithelial origin. Am J Clin Pathol. 1969;51:786-792.
34. Hicks JD. Synovial sarcoma of the tibia. J Pathol Bacteriol. 1954;67:115-161.
35. Lederer H SAJ. Malignant synovioma simulating adamantinoma of the tibia. J Pathol Bacteriol. 1954;67:163-168.
36. Benassi MS, Campanacci L, Gamberi G, et al. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula: an immunohistochemical study correlated to histogenesis. Histopathology. 1994;25:71-76.
37. Perez-Atayde AR, Kozakewich HP, Vawter GF. Adamantinoma of the tibia: an ultrastructural and immunohistochemical study. Cancer. 1985;55:1015-1023.
38. Rosai J, Pinkus GS. Immunohistochemical demonstration of epithelial differentiation in adamantinoma of the tibia. Am J Surg Pathol. 1982;6:427-434.
39. Hazelbag HM, Fleuren GJ, vd Broek LJ, Taminiau AH, Hogendoorn PC. Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis. Am J Surg Pathol. 1993;17:1225-1233.
40. Ryrie B. Adamantinoma of the tibia: etiology and pathogenesis. Br Med J. 1932;2:1000-1003.
41. Czerniak B, Rojas-Corona RR, Dorfman HD. Morphologic diversity of long bone adamantinoma: the concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer. 1989;64:2319-2134.
42. Bovee JV, van den Broek LJ, de Boer WI, Hogendoorn PC. Expression of growth factors and their receptors in adamantinoma of long bones and the implication for its histogenesis. J Pathol. 1998;184:24-30.
43. Kahn LB. Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma. Skeletal Radiol. 2003;32:245-258.
44. Hazelbag HM, Taminiau AH, Fleuren GJ, Hogendoorn PC. Adamantinoma of the long bones: a clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am. 1994;76:1482-1499.
45. Ishida T, Iijima T, Kikuchi F, et al. A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skeletal Radiol. 1992;21:493-502.
46. Qureshi AA, Shott S, Mallin BA, Gitelis S. Current trends in the management of adamantinoma of long bones: an international study. J Bone Joint Surg Am. 2000;82:1122-1131.
47. De Keyser F, Vansteenkiste J, Van Den Brande P, Demedts M, Van de Woestijne KP. Pulmonary metastases of a tibia adamantinoma: case report and review of the literature. Acta Clin Belg. 1990;45:31-33.
48. Ackerman L, Spjut HJ. Tumors of Bone and Cartilage. Washington, DC: Armed Forces Institute of Pathology; 1962.
49. Scranton PE Jr, DeCicco FA, Totten RS, Yunis EJ. Prognostic factors in osteosarcoma: a review of 20 year's experience at the University of Pittsburgh Health Center Hospitals. Cancer. 1975;36:2179-2191.
50. Meister P, Konrad EA, Wallmuller-Strycker A. [Metastasized osteosarcoma with undifferentiated carcinoma-like parts]. Arch Orthop Trauma Surg. 1980;96:75-78.
51. Yoshida H, Yumoto T, Adachi H, Minamizaki T, Maeda N, Furuse K. Osteosarcoma with prominent epithelioid features. Acta Pathol Jpn. 1989;39:439-445.
52. Hasegawa T, Shibata T, Hirose T, Seki K, Hizawa K. Osteosarcoma with epithelioid features: an immunohistochemical study. Arch Pathol Lab Med. 1993;117:295-298.
53. Kramer K, Hicks DG, Palis J, et al. Epithelioid osteosarcoma of bone: immunocytochemical evidence suggesting divergent epithelial and mesenchymal differentiation in a primary osseous neoplasm. Cancer. 1993;71:2977-2982.
54. Okada K, Hasegawa T, Yokoyama R, Beppu Y, Itoi E. Osteosarcoma with cytokeratin expression: a clinicopathological study of six cases with an emphasis on differential diagnosis from metastatic cancer. J Clin Pathol 2003;56:742-746.
55. Fanburg JC, Rosenberg AE, Weaver DL, et al. Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma. Am J Clin Pathol. 1997;108:464-473.
56. Nakajima H, Sim FH, Bond JR, Unni KK. Small cell osteosarcoma of bone: review of 72 cases. Cancer. 1997;79:2095-2106.
57. Okada K, Hasegawa T, Yokoyama R. Rosette-forming epithelioid osteosarcoma: a histologic subtype with highly aggressive clinical behavior. Hum Pathol. 2001:32:726-733.
58. Okada K, Hasegawa T, Yokoyama R, Beppu Y, Itoi E. Prognostic relevance of rosette-like features in osteosarcoma. J Clin Pathol. 2003;56:831-834.
59. Lucas DR, Unni KK, McLeod RA, O'Connor MI, Sim FH. Osteoblastoma: clinicopathologic study of 306 cases. Hum Pathol. 1994;25:117-134.
60. Schajowicz F, Lemos C. Malignant osteoblastoma. J Bone Joint Surg Br. 1976;58:202-211.
61. Dorfman HD, Weiss SW. Borderline osteoblastic tumors: problems in the differential diagnosis of aggressive osteoblastoma and low-grade osteosarcoma. Semin Diagn Pathol. 1984;1:215-234.
62. Della Rocca C, Huvos AG. Osteoblastoma: varied histological presentations with a benign clinical course: an analysis of 55 cases. Am J Surg Pathol. 1996;20:841-850.
63. Bertoni F, Unni KK, McLeod RA, Dahlin DC. Osteosarcoma resembling osteoblastoma. Cancer 1985;55:416-426.
64. Bertoni F, Bacchini P, Donati D, Martini A, Picci P, Campanacci M. Osteoblastoma-like osteosarcoma: the Rizzoli Institute experience. Mod Pathol. 1993;6:707-716.
65. Bertoni F, Unni KK, Lucas DR, MacLeod RA. Osteoblastoma with cartilaginous matrix: an unusual morphologic presentation in 18 cases. Am J Surg Pathol. 1993;17:69-74.
66. Bahk WJ, Mirra JM. Pseudoanaplastic tumors of bone. Skeletal Radiol. 2004;33:641-648.
67. Sell M, Sampaolo S, Di Lorio G, Theallier A. Chordomas: a histological and immunohistochemical study of cases with and without recurrent tumors. Clin Neuropathol. 2004;23:277-285.
68. O'Hara BJ, Paetau A, Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol. 1998;29:119-126.
69. Fan F, Templeton K, Damjanov I. Epithelioid cellular chordoma of the sacrum: a potential diagnostic problem. Ann Diagn Pathol. 2005;9:139-142.
70. Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK, Lotan R. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol Biomarkers Prev. 1995;4:871-876.
71. Laskin WB, Miettinen M. Epithelial-type and neural-type cadherin expression in malignant noncarcinomatous neoplasms with epithelioid features that involve the soft tissues. Arch Pathol Lab Med. 2002;126:425-431.
72. Fleming GF, Heimann PS, Stephens JK, et al. Dedifferentiated chordoma: response to aggressive chemotherapy in two cases. Cancer. 1993;72:714-718.
73. Dahlin DC, Ivins JC. Benign chondroblastoma: a study of 125 cases. Cancer. 1972;30:401-413.
74. de Silva MV, Reid R. Chondroblastoma: varied histologic appearance, potential diagnostic pitfalls, and clinicopathologic features associated with local recurrence. Ann Diagn Pathol. 2003;7:205-213.
75. Bertoni F, Unni KK, Beabout JW, Harner SG, Dahlin DC. Chondroblastoma of the skull and facial bones. Am J Clin Pathol. 1987;88:1-9.
76. Streitmann MJ, Sismanis A. Metastatic carcinoma of the temporal bone. Am J Otol. 1996;17:780-783.
77. Hasegawa T, Seki K, Yang P, et al. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone. Hum Pathol. 1995;26:838-845.
78. Semmelink HJ, Pruszczynski M, Wiersma-van Tilburg A, Smedts F, Ramaekers FC. Cytokeratin expression in chondroblastomas. Histopathology. 1990;16:257-263.
79. Brage ME, Simon MA. Evaluation, prognosis, and medical treatment considerations of metastatic bone tumors. Orthopedics. 1992;15:589-596.
80. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am. 1993;75:1276-1281.
81. Shih LY, Chen TH, Lo WH. Skeletal metastasis from occult carcinoma. J Surg Oncol. 1992;51:109-113.
82. Jacobsen S, Stephensen SL, Paaske BP, Lie PG, Lausten GS. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases. Acta Orthop Belg. 1997;63:15-22.
83. Nottebaert M, Exner GU, von Hochstetter AR, Schreiber A. Metastatic bone disease from occult carcinoma: a profile. Int Orthop. 1989;13:119-123.
84. Stewart WR, Gelberman RH, Harrelson JM, Seigler HF. Skeletal metastases of melanoma. J Bone Joint Surg Am. 1978;60:645-649.
85. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
86. Hasegawa T, Hirose T, Seki K, Hizawa K, Ishii S, Wakabayashi J. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas. Cancer Detect Prev. 1997;21:280-287.